FDA Inspection
Peking Medicine ManufactoryPeking Medicine Manufactory – FDA Inspection, Apr 30, 2012
Record Details
This FDA Inspection record concerns Peking Medicine Manufactory, with an inspection on April 30, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Peking Medicine Manufactory
- Inspection Date
- April 30, 2012
- Product Type
- Drugs
View Company Profile
ID · 3037609f-7144-428c-83f1-5a7ea8653496
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 782402
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
15- 21 CFR 211.80(c)Storage off Floor, Spaced Suitably
- 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
- 21 CFR 211.110(a)Control procedures fail to include the following
- 21 CFR 211.142(a)Quarantine - actual practice
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.125(f)Procedures Written and Followed
- 21 CFR 211.142Written warehousing procedures established/followed
- 21 CFR 211.125(a)Strict control not exercised over labeling issued
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
Showing 10 of 15 citations.
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.